Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases

Cancer Genetics and Cytogenetics

Volumn 144, Issue 2, 2003, Pages 125-133

  Gil Benso, Rosario ^a   López Ginés, Concha ^a   Carda, Carmen ^a   López Guerrero, José Antonio ^a   Ferrer, Jaime ^a   Pellín Pérez, Antonio ^a   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE S PHASE; CHILD; CHIMERA; CHROMOSOME ABERRATION; CORRELATION ANALYSIS; CYTOGENETICS; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FUSION; GENE OVEREXPRESSION; HETEROZYGOSITY; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA;

EID: 0038016569     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00026-8     Document Type: Article

References (43)

1. Enzinger F.M., Weiss S.N. Soft tissue tumors. 3rd edition:1995;Mosby Inc. St Louis.
2. Pappo A.S., Shapiro D.N., Crist W.M., Maurer H.M. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 13:1995;2123-2139.
3. Agamanolis D.P., Dasu S., Krill C.E. Jr. Tumors of skeletal muscle. Hum Pathol. 17:1986;778-795.
4. Barr F.G., Galili N., Holick J., Biegel J.A., Rovera G., Emanuel B.S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 3:1993;113-117.
5. Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54:1994;2869-2872.
6. Barr F.G., Nauta L.E., Davis R.J., Schafer B.W., Nycum L.M., Biegel J.A. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet. 5:1996;15-21.
7. Besnard-Guerin C., Newsham I., Winqvist R., Cavenee W.K. A common region of loss of heterozygosity in Wilms tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5. Hum Genet. 97:1996;163-170.
8. Visser M., Sijmons C., Bras J., Arceci R.J., Godfried M., Valentijn L.J., Voute P.A., Baas F. Allelotype of pediatric rhabdomyosarcoma. Oncogene. 15:1997;1309-1314.
9. Scrable H., Cavenee W., Ghavimi F., Lovell M., Morgan K., Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA. 86:1989;7480-7484.
10. Anderson J., Gordon A., McManus A., Shipley J., Pritchard-Jones K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia. 1:1999;340-348.
11. Petkovic I., Dominis M., Nakic M., Cepulic M. Embryonal rhabdomyosarcoma with 92,XXYY, +dmin and evidence of spontaneous cell fusion. Cancer Genet Cytogenet. 76:1994;125-128.
12. Anderson J., Gordon A., Pritchard-Jones K., Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer. 26:1999;275-285.
13. Driman D., Thorner P.S., Greenberg M.L., Chilton-MacNeill S., Squire J. MYCN gene amplification in rhabdomyosarcoma. Cancer. 73:1994;2231-2237.
14. Steilen-Gimbel H., Remberger K., Graf N., Steudel W.I., Zang K.D., Henn W. A novel site of DNA amplification on chromosome 1p32-33 in a rhabdomyosarcoma revealed by comparative genomic hybridization. Hum Genet. 97:1996;87-90.
15. Bridge J.A., Liu J., Weibolt V., Baker K.S., Perry D., Kruger R., Qualman S., Barr F., Sorensen P., Triche T., Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer. 27:2000;337-344.
16. Weber-Hall S., Anderson J., McManus A., Abe S., Nojima T., Pinkerton R., Pritchard-Jones K., Shipley J. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res. 56:1996;3220-3224.
17. Weber-Hall S., McManus A., Anderson J., Nojima T., Abe S., Pritchard-Jones K., Shipley J. Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 17:1996;7-13.
18. Sharpless N.E., DePinho R.A. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev. 9:1999;22-30.
19. Hollstein M., Hergenhahn M., Yang Q., Bartsch H., Wang Z.Q., Hainaut P. New approaches to understanding p53 gene tumor mutation spectra. Mutat Res. 431:1999;199-209.
20. Gil-Benso R., Carda-Batalla C., Navarro-Fos S., Pellin-Perez A., Llombart-Bosch A. Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland. Cancer Genet Cytogenet. 109:1999;150-153.
21. ISCN. An international system for human cytogenetic nomenclature. Mitelman F. 1995;S. Karger, Basel.
22. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.J., Emanuel B.S., Rovera G., Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 5:1993;230-235.
23. Anderson J., Renshaw J., McManus A., Carter R., Mitchell C., Adams S., Pritchard-Jones K. Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction. Am J Pathol. 150:1997;477-482.
24. Crabbe D.C., Peters J., Seeger R.C. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol. 1:1992;229-234.
25. Sambrook J., Fritsch F.E., Maniatis T. Molecular cloning. A Laboratory Manual. 2nd edition:1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Lopez-Guerrero J.A., Pellin A., Noguera R., Carda C., Llombart-Bosch A. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest. 81:2001;803-814.
27. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:1996;9821-9826.
28. Bennicelli J.L., Fredericks W.J., Wilson R.B., Rauscher F.J. III, Barr F.G. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene. 11:1995;119-130.
29. Koi M., Johnson L.A., Kalikin L.M., Little P.F., Nakamura Y., Feinberg A.P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science. 260:1993;361-364.
30. Barr F.G., Qualman S.J., Macris M.H., Melnyk N., Lawlor E.R., Strzelecki D.M., Triche T.J., Bridge J.A., Sorensen P.H. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res. 62:2002;4704-4710.
31. Frascella E., Lenzini E., Schafer B.W., Brecevic L., Dorigo E., Toffolatti L., Nanni P., De Giovanni C., Rosolen A. Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdo- myosarcoma cell line carrying a cryptic (1;13)(p36;q14). Cancer Genet Cytogenet. 121:2000;139-145.
32. Kelly K.M., Womer R.B., Sorensen P.H., Xiong Q.B., Barr F.G. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol. 15:1997;1831-1836.
33. Sorensen P.H., Lynch J.C., Qualman S.J., Tirabosco R., Lim J.F., Maurer H.M., Bridge J.A., Crist W.M., Triche T.J., Barr F.G. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. 20:2002;2672-2679.
34. Gordon T., McManus A., Anderson J., Min T., Swansbury J., Pritchard-Jones K., Shipley J. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a UK Cancer Cytogenetics Group study. Med Pediatr Oncol. 36:2001;259-267.
35. Lee W., Han K., Harris C.P., Meisner L.F. Detection of aneuploidy and possible deletion in paraffin-embedded rhabdomyosarcoma cells with FISH. Cancer Genet Cytogenet. 68:1993;99-103.
36. Albrecht S., von Schweinitz D., Waha A., Kraus J.A., von Deimling A., Pietsch T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res. 54:1994;5041-5044.
37. Donner L.R. Cytogenetics and molecular biology of small round-cell tumors and related neoplasms. Current status. Cancer Genet Cytogenet. 54:1991;1-10.
38. Brodeur G.M., Seeger R.C. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications. Cancer Genet Cytogenet. 19:1986;101-111.
39. Hachitanda Y., Toyoshima S., Akazawa K., Tsuneyoshi M. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features. Mod Pathol. 11:1998;1222-1227.
40. Maelandsmo G.M., Berner J.M., Florenes V.A., Forus A., Hovig E., Fodstad O., Myklebost O. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer. 72:1995;393-398.
41. Iolascon A., Faienza M.F., Coppola B., Rosolen A., Basso G., Della Ragione F., Schettini F. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer. 15:1996;217-222.
42. Taylor A.C., Shu L., Danks M.K., Poquette C.A., Shetty S., Thayer M.J., Houghton P.J., Harris L.C. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol. 35:2000;96-103.
43. Orlow I., Drobnjak M., Zhang Z.F., Lewis J., Woodruff J.M., Brennan M.F., Cordon-Cardo C. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst. 91:1999;73-79.